A multicentric prospective observational study of diagnosis and prognosis features in ICU mesenteric ischemia: the DIAGOMI study

Simon Bourcier,Guillaume Ulmann,Matthieu Jamme,Guillaume Savary,Marine Paul,Sarah Benghanem,Jean-Rémi Lavillegrand,Matthieu Schmidt,Charles-Edouard Luyt,Eric Maury,Alain Combes,Frédéric Pène,Nathalie Neveux,Alain Cariou
DOI: https://doi.org/10.1186/s13613-022-01092-8
IF: 10.318
2022-12-19
Annals of Intensive Care
Abstract:Non-occlusive mesenteric ischemia (NOMI) is a challenging diagnosis and is associated with extremely high mortality in critically ill patients, particularly due to delayed diagnosis and when complicated by intestinal necrosis. Plasma citrulline and intestinal-fatty acid binding protein (I-FABP) have been proposed as potential biomarkers, but have never been studied prospectively in this setting. We aimed to investigate diagnostic features, the accuracy of plasma citrulline and I-FABP to diagnose NOMI and intestinal necrosis as well as prognosis.
critical care medicine
What problem does this paper attempt to address?